医药行业分析
- (2022-02-19)
- (2022-02-19)
丙酮酸激酶缺乏症的首个疾病纠正疗法(PKD)!FDA批准第一个口服PK变构激活剂pyrokynd(mitapivat)!
(2022-02-19)- (2022-02-19)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-18)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-17)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-16)
- (2022-02-15)
- (2022-02-15)
- (2022-02-15)
- (2022-02-14)
- (2022-02-14)
- (2022-02-14)
- (2022-02-13)
- (2022-02-13)
- (2022-02-13)
- (2022-02-13)
- (2022-02-12)
- (2022-02-12)
- (2022-02-12)
- (2022-02-12)
- (2022-02-12)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-11)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-09)